Leaderboards/Heparin-Induced Thrombocytopenia and Thrombosis

Heparin-Induced Thrombocytopenia and Thrombosis

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Nina Haagenrud Schultz
Oslo University Hospital
2
Joana Barros‐Martins
Medizinische Hochschule Hannover
3
Eun‐Ju Lee
NewYork–Presbyterian Hospital
4
Jacqui Wise
Transnational Press London
5
Iliès Benotmane
Université de Strasbourg
6
Hannah G. Rosenblum
National Center for Immunization and Respiratory Diseases
7
Alex Bourguignon
Centre Hospitalier de l’Université de Montréal
8
Mayte Sánchez van Kammen
Amsterdam University Medical Centers
9
Mansour Tobaiqy
University of Jeddah
10
Marie-Joëlle Jabagi
Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail

Rising Stars Papers

1
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
International Journal of Clinical Pharmacy|2024
79 cit.
2
Nirsevimab Effectiveness at Preventing RSV-Related Hospitalization in Infants
NEJM Evidence|2025
36 cit.
3
Global life expectancy to increase by almost five years by 2050, study predicts
BMJ|2024
21 cit.
4
Substance misuse disorder in Saudi Arabia: A comprehensive examination of current demographic patterns, trends, and intervention requirements
Saudi Pharmaceutical Journal|2024
13 cit.
5
Covid-19: Two rare vaccine side effects detected in large global study
BMJ|2024
12 cit.
6
UK-US pharmaceutical deal: NHS will pay billions more for new drugs
BMJ|2025
12 cit.
7
Measles: Birmingham outbreak declared a national incident and likely to spread
BMJ|2024
11 cit.
8
Exploring medical students’ preferences and challenges in clinical pharmacology education: insights and improvement strategies
BMC Medical Education|2025
11 cit.
9
RCP members vote to limit physician associate roles amid calls for president to resign
BMJ|2024
10 cit.
10
Valproate: Men planning a family should seek advice in light of neurodevelopmental disorders risk in children, says regulator
BMJ|2024
9 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Ishac Nazy
McMaster University
2
Matthew Lynch
Royal College of Surgeons in Ireland
3
L. Zambreanu
Watford General Hospital
4
Muaamar Traqchi
Philadelphia University
5
Karim Merouani
Unknown
6
Liang Hu
First Affiliated Hospital of Zhengzhou University
7
Narayan Nair
Center for Biologics Evaluation and Research
8
Esmaeil Soomari
Iran University of Medical Sciences
9
Björn Tampe
Universitätsmedizin Göttingen
10
Claudius Speer
Heidelberg University

Emerging Leaders Papers

1
Galectin 3 enhances platelet aggregation and thrombosis via Dectin-1 activation: a translational study
European Heart Journal|2022
53 cit.
2
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
American Journal of Transplantation|2022
48 cit.
3
Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation
Journal of Thrombosis and Haemostasis|2023
40 cit.
4
Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT
Journal of Thrombosis and Haemostasis|2023
34 cit.
5
VITT-like Monoclonal Gammopathy of Thrombotic Significance
New England Journal of Medicine|2025
34 cit.
6
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
Blood Advances|2022
30 cit.
7
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia
Blood Advances|2022
30 cit.
8
Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2
Frontiers in Immunology|2022
26 cit.
9
Understanding the factors influencing community pharmacist retention – A qualitative study
Exploratory Research in Clinical and Social Pharmacy|2023
24 cit.
10
Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid
Frontiers in Medicine|2022
23 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Andreas Greinacher
Universitätsmedizin Greifswald
2
Pieter H. Reitsma
Leiden University Medical Center
3
Theodore E. Warkentin
Hamilton General Hospital
4
Zaverio M. Ruggeri
Scripps Research Institute
5
Richard H. Aster
Versiti Blood Center of Wisconsin
6
Sabine Eichinger
Medical University of Vienna
7
Jeffrey Laurence
Cornell University
8
Beng H. Chong
The University of Texas Southwestern Medical Center
9
Yves Gruel
Centre Hospitalier Universitaire de Tours
10
Pål André Holme
Oslo University Hospital

Current Senior Leaders Papers

1
Mutation in blood coagulation factor V associated with resistance to activated protein C
Nature|1994
3.8k cit.
2
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
New England Journal of Medicine|1995
2.3k cit.
3
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
New England Journal of Medicine|2021
2.3k cit.
4
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Translational research|2020
2.3k cit.
5
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
New England Journal of Medicine|2021
1.5k cit.
6
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
Cell|1996
1.2k cit.
7
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings
Journal of Thrombosis and Haemostasis|2006
998 cit.
8
Temporal Aspects of Heparin-Induced Thrombocytopenia
New England Journal of Medicine|2001
975 cit.
9
Impact of the patient population on the risk for heparin-induced thrombocytopenia
Blood|2000
912 cit.
10
A 14-year study of heparin-induced thrombocytopenia
The American Journal of Medicine|1996
894 cit.

Reagents for Heparin-Induced Thrombocytopenia and Thrombosis

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Acris Antibodies

Mouse Anti-CD154 / CD40L Monoclonal Antibody, Unconjugated Clone 2A3

#4CD40-2A3
View Evidence →
Cell Signaling TechnologyEvidence 66

EpCAM (D4K8R) Rabbit Monoclonal Antibody (SignalFlex™ Pacific Blue™ Conjugate)

#29202$458
View Evidence →
Cell Signaling TechnologyEvidence 67

CASK Antibody

#2878$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

ZAP (E5V4D) Rabbit Monoclonal Antibody

#33750$161,351
View Evidence →
InnoCytoEvidence 66

Anti-c-Myc Antibody

#300901
View Evidence →
Acris AntibodiesEvidence 60

Mouse Anti-Canine Distemper Virus Monoclonal Antibody, Unconjugated, Clone 39937

#3CD10-5-4
View Evidence →